How This Fund’s Investments in NorthStar Asset Management (NSAM), CONMED Corporation (CNMD) & Other Stocks Performed in Q3?

SLS Management closed its stake in CONMED Corporation (NASDAQ:CNMD), having unloaded 96,001 shares it had held at the end of June. The move was made as the stock lost 15.7% between July and September. The number of funds followed by us long CONMED Corporation increased by one to 16 during the second quarter. Among these funds, Scopia Capital held the largest stake in CONMED Corporation (NASDAQ:CNMD), which was worth $132.4 million at the end of June. Trailing Scopia Capital was Fisher Asset Management, which amassed a stake valued at $21.8 million. Huber Capital Management, Point72 Asset Management, and Ghost Tree Capital also held valuable positions in the company.

Myriad Genetics, Inc. (NASDAQ:MYGN) is another company that SLS Management dumped during the third quarter as the stock plunged by 32.7%. In this way, the fund sold all of its 109,300 shares it had reported in its 13F for the second quarter. At the end of June, 28 of the hedge funds tracked by Insider Monkey were long this stock, up by 33% over the quarter. Among these funds, Scopia Capital held the most valuable stake in Myriad Genetics, Inc. (NASDAQ:MYGN), which was worth $142.4 million at the end of the second quarter. On the second spot was Iridian Asset Management which amassed $98.4 million worth of shares. Moreover, D E Shaw, Renaissance Technologies, and Royce & Associates were also bullish on Myriad Genetics, Inc. (NASDAQ:MYGN).

Disclosure: none